Skip to main content

News

By Bill Siwicki | 11:42 am | July 11, 2023
Virtual care provider Ophelia found 56% of its OUD patients remained in treatment for six months and 48% stayed for one year, with retention rates significantly higher than traditional in-person care.
By Mike Miliard | 11:21 am | July 11, 2023
The health system says the patient data, which was posted online, includes names, phone numbers and appointment information, but not clinical or payment info.
By Adam Ang | 03:16 am | July 11, 2023
It also helped the hospital gain around $1.8 million in productivity.
By Adam Ang | 03:12 am | July 11, 2023
Based on OpenAI, it will enable healthcare professionals to automate tasks and generate insights.
By Bill Siwicki | 11:52 am | July 10, 2023
The CEO of Summus Global discusses how virtual specialty care can help overcome patient access challenges – and talks about how employer-sponsored telehealth is one key component.
By Jeff Lagasse | 03:49 pm | July 07, 2023
 Dr. Kristi Henderson is making the transition after 25 years of experience in various healthcare leadership roles.
By Andrea Fox | 03:20 pm | July 07, 2023
The study of 1.7 billion clinical notes over a three-year period found an increase in the use of digital tools and copy/paste functionality correlated with longer notes and a decrease in the average time spent writing notes.
By Jessica Hagen | 02:29 pm | July 07, 2023
Ralf-Gordon Jahns, managing director of Research2Guidance, joins MobiHealthNews to discuss R2G's findings on effective monetization strategies for digital health solutions.
By Bill Siwicki | 11:16 am | July 07, 2023
Tracy Warren, CEO of Astarte Medical and a former venture investor, talks the best data, the pace of tech innovation, curbing the all-time high in premature births, and best practices to prevent lapses and medical errors in the neonatal intensive care unit.
By Andrea Fox | 10:58 am | July 07, 2023
The company told the American Diabetes Association that the metabolic monitor could reduce down-the-line healthcare costs for T2 non-insulin users and others. "These trends have to change," says CEO Kevin Sayer.